The role of anti-cyclic citrullinated peptide (CCP) antibodies in early detection of rheumatoid arthritis: an overview of the INOVA Diagnostics, Inc. QUANTA Lite CCP assays

Bibliography

• Enriconi dos Anjos LM, Pereira IA, d'Orsi E, A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis. Clin Rheumatol 2009;28:153-8
   PubMed Web of Science ®Google Scholar
• Caro-Oleas JL, Fernandez-Suarez A, Cesteros SR, Diagnostic usefulness of a third-generation anti-cyclic citrulline antibody test in patients with recent-onset polyarthritis. Clin Chem Lab Med 2007;45:1396-401
   PubMed Web of Science ®Google Scholar
• Coenen D, Verschueren P, Westhovens R, Bossuyt X. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Chem 2007;53:498-504
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24
   PubMed Web of Science ®Google Scholar
• Puszczewicz M, Iwaszkiewicz Cd'Orsi E. Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis. Arch Med Sci 2011;7:189-94
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, 2010 rheumatoid arthritis classification criteria – An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81
   PubMed Web of Science ®Google Scholar
• Schellekens GA, de Jong BA, van den Hoogen FH, Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-81
   PubMed Web of Science ®Google Scholar
• van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 2002;4:87-93
   PubMedGoogle Scholar
• Lutteri L, Malaise M, Chapelle JP. Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis. Clin Chim Acta 2007;386:76-81
   PubMed Web of Science ®Google Scholar
• Santiago M, Baron M, Miyachi K, A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis. Clin Rheumatol 2008;27:77-83
   PubMed Web of Science ®Google Scholar
• Klareskog L, Ronnelid J, Lundberg K, Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 2008;26:651-75
   PubMed Web of Science ®Google Scholar
• Rantapaa-Dahl qvist S, de Jong BA, Berglin E, Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9
   PubMed Web of Science ®Google Scholar
• Nielen MM, van Schaardenburg D, Reesink HW, Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380-6
   PubMed Web of Science ®Google Scholar
• Berglin E, Johansson T, Sundin U, Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA RF at disease onset. Ann Rheum Dis 2006;65:453-8
   PubMed Web of Science ®Google Scholar
• van Venrooij WJ, van Beers JJBC, Pruijn GJM. Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol 2011;7:391-8
   PubMed Web of Science ®Google Scholar
• Kitahara K, Takagi K, Kusunoki Y, Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis. Ann Rheum Dis 2008;67:1059-60
   PubMed Web of Science ®Google Scholar
• Shidara K, Inoue E, Tanaka E, Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis. Rheumatol Int 2011;31:617-22
   PubMed Web of Science ®Google Scholar
• Fernandez-Suarez A, Reneses S, Wichmann I, Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis. Clin Chem Lab Med 2005;43:1234-9
   PubMed Web of Science ®Google Scholar
• Szekanecz Z, Tumpek J, Szabo Z, The INOVA CCP3.1 IgA/IgG ELISA represents significant improvement in the laboratory diagnosis of rheumatoid arthritis. Arthritis Rheum 2007;56:S716
   Google Scholar
• Vieira LMEA, Pereira IA, D'dorsi E, Rheumatoid arthritis diagnosis: a comparative study of second and third generation anti-cyclic citrullinated peptide (CCP) antibody ELISAs. Arthritis Rheum 2007;56:S724
   Google Scholar
• da Mota LM, Santos Neto LL, Pereira IA, Autoantibodies in early rheumatoid arthritis: Brasilia cohort: results of a three-year serial analysis. Rev Bras Reumatol 2011;51:558-71
   Google Scholar
• Silveira IG, Burlingame RW, von Mullen CA, Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF. Clin Rheumatol 2007;26:1883-9
   PubMed Web of Science ®Google Scholar
• Mjaavatten MD, van der Heijde DM, Uhlig T, Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of follow-up in recent-onset arthritis? A longitudinal study. J Rheumatol 2011;38:2336-41
   PubMed Web of Science ®Google Scholar
• Skare TS, Nisihara RM, Silva RM, Anti-cyclic citrullinated peptide antibodies in adult patients with juvenile idiopathic arthritis. J Clin Rheumatol 2011;17:421-3
   PubMed Web of Science ®Google Scholar
• da Mota LM, dos Santos Neto LL, de Carvalho JF, The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years. Rheumatol Int 2011; [Epub ahead of print]
   Google Scholar
• Wu R, Shovman O, Zhang Y, Increased prevalence of anti-third generation cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and CREST syndrome. Clin Rev Allergy Immunol 2007;32:47-55
   PubMed Web of Science ®Google Scholar
• Hjeltnes G, Hollan I, Førre Ø, Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients. Scand J Rheumatol 2011;40:422-7
   PubMed Web of Science ®Google Scholar
• Liao KP, Alferdsson L, Karlson EW. Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol 2009;21:272-8
   PubMedGoogle Scholar
• Toussirot E, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol 2008;22:883-96
   PubMed Web of Science ®Google Scholar
• Yazbek MA, de Barros-Mazon S, Rossi C, Association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared eptitope and smoking status in Brazilian patients with rheumatoid arthritis. Clinics (Sao Paulo) 2011;66:1401-6
   PubMed Web of Science ®Google Scholar
• Bellatin MF, Han M, Fallena M, Production of autoantibodies against citrullinated antigens/peptides by human B cells. J Immunol 2012;188:000-0
   Google Scholar
• Lal P, Su Z, Holweg CTJ, Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment. Arthritis Rheum 2011;63:3681-91
   PubMed Web of Science ®Google Scholar
• Elrefaei M, Boose K, McGee M, Second generation automated anti-CCP test better predicts the clinical diagnosis of rheumatoid arthritis. J Clin Immunol 2012;32:131-7
   PubMed Web of Science ®Google Scholar
• Correia ML, Carvalho S, Fortuna J, Pereira MH. Comparison of three anti-CCP antibody tests and rheumatoid factor in RA and control patients. Clin Rev Allergy Immunol 2008;34:21-5
   PubMed Web of Science ®Google Scholar
• Block DR, Jenkins SM, Dalenberg DA, Analytical and clinical comparison of anti-CCP assays with rheumatoid factor for the diagnosis of rheumatoid arthritis. Clin Chim Acta 2012;413:1015-17
   PubMed Web of Science ®Google Scholar
• van der Linden MPM, van der Woude D, Ioan-Facsinay A, Value of anti-modified citrullinated vimentin and third generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. Arthritis Rheum 2009;60:2232-41
   PubMed Web of Science ®Google Scholar
• Bartoloni E, Alunno A, Bistoni O, Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature. Autoimmun Rev 2012; [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Damjanovska L, Thabet MM, Levarth EWN, Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis. Ann Rheum Dis 2010;69:730-2
   PubMed Web of Science ®Google Scholar
• Innala L, Kokkonen H, Eriksson C, Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides. J Rheumatol 2008;35:1002-8
   PubMed Web of Science ®Google Scholar
• Snir O, Widhe M, Hermansson M, Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. Ann Rheum Dis 2010;62:44-52
   Google Scholar
• Syed RH, Gilliam BE, Moore TL. Rheumatoid factors and anti-cyclic citrullinated peptide antibodies in pediatric rheumatology. Curr Rheumatol Rep 2008;10:156-63
   PubMedGoogle Scholar
• Gilliam BE, Reed MR, Chauhan AK, Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis. Pediatr Rheumatol 2011;9:8
   PubMedGoogle Scholar
• Syed RH, Gilliam BE, Moore TL. Prevalence and significance of isotypes of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2008;67:1049-51
   PubMed Web of Science ®Google Scholar